grant

Contribution of FGF21 and macronutrient composition towards Glp1r agonist-induced weight loss

Organization VANDERBILT UNIVERSITYLocation Nashville, UNITED STATESPosted 1 Apr 2026Deadline 31 Mar 2029
NIHUS FederalResearch GrantFY2026ACTH-beta-Lipotropin PrecursorAdult-Onset Diabetes MellitusAffectAgonistBackBlood PlasmaBody WeightBody Weight decreasedBrainBrain Nervous SystemBreedingCNS Nervous SystemCarbohydratesCentral Nervous SystemClinical TrialsCommunicationComplexConsumptionCorticotropin-beta-Lipotropin PrecursorD-GlucoseDataData AnalysesData AnalysisDextroseDietDietary CarbohydratesDorsumDrugsEatingEffectivenessEncephalonEndocrine Gland SecretionEndorphin-ACTH PrecursorExperimental DesignsFGF-21FatsFatty acid glycerol estersFeedsFood IntakeFood PreferencesGLP-1GLP-1 RAGLP-1 agonistGLP-1 analogGLP-1 receptorGLP-1 receptor agonistGLP-I receptorGlp-1Glucagon like peptide 1 agonistGlucagon like peptide-1 receptor agonistsGlucagon-like peptide-1 analogGlucoseGoalsHigh Fat DietHormonesImaging ProceduresImaging TechnicsImaging TechniquesImpairmentIndividualIntakeIntermediate Hypothalamic RegionInvestigationInvestigatorsKO miceKetosis-Resistant Diabetes MellitusKnock-outKnock-out MiceKnockoutKnockout MiceKnowledgeLearningLiverMacronutrientsMacronutrients NutritionMaintenanceMaturity-Onset Diabetes MellitusMedial HypothalamusMediatingMedicationMentorsMetabolic DiseasesMetabolic DisorderMethodsMiceMice MammalsMiddle HypothalamusModelingMurineMusNIDDMNerve CellsNerve UnitNeural CellNeuraxisNeurocyteNeuroendocrinologyNeuronsNon-Insulin Dependent DiabetesNon-Insulin-Dependent Diabetes MellitusNoninsulin Dependent DiabetesNoninsulin Dependent Diabetes MellitusNull MouseObesityOralOutcomeOzempicPharmaceutical PreparationsPlasmaPlasma SerumPlayPro-ACTH-EndorphinPro-Opio-MelanocortinPro-OpiocortinPro-OpiomelanocortinProopiocortinProopiomelanocortinPublishingR-Series Research ProjectsR01 MechanismR01 ProgramReceptor ActivationReceptor ProteinRegulationResearchResearch GrantsResearch PersonnelResearch Project GrantsResearch ProjectsResearchersReticuloendothelial System, Serum, PlasmaRewardsRoleRybelsusSaccharoseScientistSlow-Onset Diabetes MellitusSourceStable Diabetes MellitusStarchSucroseT2 DMT2DT2DMTechniquesTestingTherapeuticThesaurismosisTrainingType 2 Diabetes MellitusType 2 diabetesType II Diabetes MellitusType II diabetesWegovyWeightWeight LossWeight Loss AgentsWeight ReductionWeight-Loss DrugsWorkWritingadiposityadult onset diabetesanalogbehavior phenotypebehavioral phenotypingbody weight losscareerclinical applicabilityclinical applicationcorpulencedata interpretationdiet choicediet preferencedietary choicedietary preferencesdietsdrug/agentexperimentexperimental researchexperimental studyexperimentsfibroblast growth factor 21food choiceglucagon-like peptide 1glucagon-like peptide-1 receptorhepatic body systemhepatic organ systeminsightketosis resistant diabetesliraglutidematurity onset diabetesmetabolic phenotypemetabolism disordermetabotypeneuronalnovelobesity managementpersonalization of treatmentpersonalized medicinepersonalized therapypersonalized treatmentpharmacologicpreferencereceptorresponsesemaglutidesensorskillssocial rolesugartraining opportunitytype 2 DMtype II DMtype two diabetesweightswt-loss
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Project Summary/ Abstract
Glucagon-like peptide-1 (Glp1) receptor (Glp1r) agonists are a promising new class of weight loss drugs for

treating obesity, yet weight loss outcomes to Glp1r agonists range from 0% to over 20% of starting body weight

which raises the critical question of why some individuals are more responsive than others. Previous…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Contribution of FGF21 and macronutrient composition towards Glp1r agonist-induced weight loss — VANDERBILT UNIVERSITY | | Dev Procure